Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited

Informe acción SHSE:600329

Capitalización de mercado: CN¥22.3b

Tianjin Pharmaceutical Da Ren Tang Group Dirección

Dirección controles de criterios 1/4

Actualmente no disponemos de información suficiente sobre el CEO.

Información clave

Lei Wang

Chief Executive Officer (CEO)

CN¥2.6m

Compensación total

Porcentaje del salario del CEOn/a
Permanencia del CEO2.3yrs
Participación del CEOn/a
Permanencia media de la dirección2.4yrs
Promedio de permanencia en la Junta Directiva2.9yrs

Actualizaciones recientes de la dirección

Recent updates

Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?

Oct 27
Are Investors Undervaluing Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329) By 48%?

Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge

Oct 08
Why Investors Shouldn't Be Surprised By Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) 36% Share Price Surge

Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio

Jul 26
Some Shareholders Feeling Restless Over Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited's (SHSE:600329) P/E Ratio

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Jul 05
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Apr 18
Fewer Investors Than Expected Jumping On Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SHSE:600329)

Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

Mar 18
Tianjin Pharmaceutical Da Ren Tang Group (SHSE:600329) Has A Rock Solid Balance Sheet

CEO

Lei Wang (53 yo)

2.3yrs

Permanencia

CN¥2,625,100

Compensación

Ms. Lei Wang serves as Executive Director of Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited since December 30, 2022 and serves as its General Manager since August 22, 2022. She served as Gene...


Equipo directivo

NombrePosiciónPermanenciaCompensaciónPropiedad
Lei Wang
GM & Executive Director2.3yrsCN¥2.63msin datos
Jian Ma
Chief Financial Officer1.3yrsCN¥190.30ksin datos
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
CN¥ 690.2k
Min Guo
Executive Directorno datasin datossin datos
Yu Zhang
Chief Manufacturing Officer2.6yrsCN¥893.80ksin datos
Mingjie Shang
Executive Directorless than a yearCN¥299.00ksin datos
Yan Jiao
Secretary to the Board of Directors16.9yrsCN¥445.80k0.0013%
CN¥ 294.9k

2.4yrs

Permanencia media

53yo

Promedio de edad

Equipo directivo experimentado: El equipo directivo de 600329 se considera experimentado (2.4 años antigüedad media).


Miembros de la Junta

NombrePosiciónPermanenciaCompensaciónPropiedad
Lei Wang
GM & Executive Director1.9yrsCN¥2.63msin datos
Hong Zhou
Deputy GM5.5yrsCN¥1.38m0.0031%
CN¥ 690.2k
Min Guo
Executive Director3.3yrssin datossin datos
Mingjie Shang
Executive Director1.4yrsCN¥299.00ksin datos
Yoke Pheng Liew
Independent & Non-Executive Director4.4yrsCN¥259.16ksin datos
Yuanxia Wang
Chairman of Board of Supervisors4.9yrssin datossin datos
Jianhua Xing
Supervisor2.9yrssin datossin datos
Mingrui Zhang
Non-Executive & Non-Independent Chairman2.9yrssin datossin datos
Weiwen Mao
Non-Executive Non-Independent Director1.9yrssin datossin datos
Guat Kwang Yeo
Lead Independent Directorless than a yearsin datossin datos
Ming Zhong
Independent Directorless than a yearsin datossin datos

2.9yrs

Permanencia media

53yo

Promedio de edad

Junta con experiencia: La junta directiva de 600329 no se considera experimentada (2.9 años de permanencia promedio), lo que sugiere una nueva junta directiva.